Stem Pharm, Incorporated

Fitchburg, WI Doing business as Stem Pharmacy

UEI
YTLQLAJ53CB7
CAGE
7ALR5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
5520 Nobel Dr #150, Fitchburg, WI 53711, USA
Website
stempharm.com
Founded
2015
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Stem Pharm, Incorporated

Stem Pharm, Incorporated, doing business as Stem Pharmacy, is a corporate entity registered in SAM.gov since February 23, 2015, with a current registration valid through October 22, 2025. The company is a self-certified small disadvantaged business and for-profit organization that specializes in manufacturing goods, with a specific focus on developing advanced neural organoid models for medical research. Located in Fitchburg, Wisconsin, Stem Pharm appears to be a biotechnology research company that leverages human stem cell technologies to create innovative cellular models for studying neurological conditions and potential therapeutic interventions.

The company has been awarded multiple federal grants from prominent research institutions, including the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Aging, and the National Cancer Institute. These grants, ranging from approximately $499,953 to an unspecified amount, have supported the development of sophisticated neural organoid models for researching complex neurological conditions such as temporal lobe epilepsy, Alzheimer's disease, and glioblastoma. Specifically, Stem Pharm's grant-funded projects involve creating advanced in vitro models that incorporate microglia and can simulate neuroinflammatory processes, enabling more precise drug discovery and therapeutic research. The company's work focuses on developing reproducible, 96-well plate format neural organoids that can model intricate cellular interactions, inflammation responses, and potential treatment mechanisms for various neurological disorders, with an emphasis on creating more biologically relevant research platforms that can potentially accelerate drug development and understanding of complex neural pathologies.

SBA capabilities narrative

Contract research services, product development, assay development, hydrogel manufacturing, quality control testing

Quick answers

What is Stem Pharm, Incorporated's UEI?

Stem Pharm, Incorporated's Unique Entity ID (UEI) in SAM.gov is YTLQLAJ53CB7.

What is Stem Pharm, Incorporated's CAGE code?

Stem Pharm, Incorporated's CAGE code is 7ALR5.

What is Stem Pharm, Incorporated's primary NAICS code?

Stem Pharm, Incorporated's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Stem Pharm, Incorporated located?

Stem Pharm, Incorporated's physical address in SAM.gov is 5520 Nobel Dr #150, Fitchburg, WI 53711, USA.

Is Stem Pharm, Incorporated registered in SAM.gov?

Stem Pharm, Incorporated's SAM.gov registration expired on October 7, 2026.

What is Stem Pharm, Incorporated's most recent federal award?

Stem Pharm, Incorporated's most recent federal grant award is Development and validation of a CNS organoid model of temporal lobe epilepsy for drug discovery - project… (R43NS139845), from National Institute of Neurological Disorders and Stroke, on September 15, 2024.

On GovTribe

See Stem Pharm, Incorporated's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors